The health plans are under extreme pressure to grow revenue and expand margin. Health plans compete on performance, for which, Star Ratings, Quality Bonus Payments, and risk-adjusted revenue are core metrics. They shape margin, growth, and market position. A major constraint to the above is the ability to ingest, validate, and use clinical data effectively at scale.
In MY24, a National Blue Plan demonstrated what changes when clinical data ingestion becomes precise, automated, and audit-ready. By closing 29% more HEDIS gaps across 11 key measures, the plan unlocked an estimated $128M in incremental annual revenue and positively impacted 680,000 members.
This was not achieved through incremental workflow improvement. It was achieved by strengthening the clinical data foundation.
What Does “Closing HEDIS Gaps” Actually Mean for Health Plans
HEDIS gap closure is the process of ensuring that required quality measures are both satisfied and supported by valid clinical or administrative evidence within the measurement year (MY).
For example, if documentation confirming a colorectal screening, blood pressure control, or care for older adults is not properly ingested and structured, the measure remains open—even if care was delivered.
Under CMS and NCQA reporting requirements, evidence must be structured, standardized where applicable, and auditable. Claims data alone does not provide complete coverage across all measures. A significant portion of required quality evidence resides in clinical records originating from provider EMRs.
When that data fails during ingestion or validation, plans may lose reportable value tied to the delivered care. This, in turn, negatively impacts revenue and ratings.
Why Accurate Clinical Data Ingestion Matters for Health Plans
For Medicare Advantage and Medicaid plans, HEDIS performance directly influences CMS Star Ratings, which, in turn, drives Quality Bonus Payments. Since these bonus payments compound over time, the financial implications and outcomes of accurate clinical data ingestion are paramount.
The National Blue Plan’s 2024 results illustrate the structural opportunity. Clinical Data Ingestion accounted for 29% of member gap closures across 11 measures, including Controlling High Blood Pressure (CBP), Hemoglobin A1c Control for Patients with Diabetes (HBD), Colorectal Cancer Screening (COL), Care for Older Adults (COA) and Breast Cancer Screening (BCS)—high-impact categories tied to quality scoring.
The implication is clear. When clinical data ingestion is incomplete or inconsistent, performance remains constrained by missing or unusable documentation.
Constraints to Clinical Data Ingestion at Scale
Health plans receive data from thousands of provider systems, in various formats, with different schemas. Approximately 80% of clinical data is unstructured.
Traditional ingestion models rely on manual ETL pipelines and rule-based mapping. Each new provider format requires new transformation logic. Review cycles stretch for weeks. Even then, records are often rejected downstream in the HEDIS engine, while submission windows narrow.
This introduces three systemic risks:
Gaps remain open despite delivered care
Audit exposure increases due to incomplete documentation
Operational cost escalates through manual review cycles
The issue is less about volume alone and more about normalization and validation.
How HiLabs® Clinical Data Ingestion Supports HEDIS Gap Closure
HiLabs® Clinical Data Ingestion (CDI) automates ingestion, normalization, and validation of clinical data from any EMR or file format. The system is schema-independent and powered by an AI Auto-Mapper and a Data Quality Engine with more than 200 out-of-the-box checks.
Clinical data is standardized before it reaches downstream quality systems. Errors are identified upstream. Usable records are preserved through partial file processing instead of rejecting an entire file.
The operational impact is measurable:
96% of clinical data is ingested without human intervention.
Business review time of ingested data is reduced by 90%, from 2–3 weeks to 1–2 days.
Full refresh cycles decline from 6.5 days to under 24 hours.
Manual workload across QA, mapping, and transformation is reduced by 85%.
Annual operational savings exceeded $5M.
Regulatory Alignment
CMS Star Ratings programs and NCQA HEDIS reporting frameworks require complete, validated, and traceable documentation within defined measurement periods. Incomplete ingestion introduces audit exposure and can reduce reporting performance.
By applying 200+ automated data quality checks before data enters the HEDIS engine, CDI strengthens compliance posture while improving quality performance.
Health plans improve HEDIS outcomes more effectively when they ingest clinical data accurately, at scale, and within measurement timelines.
Conclusion: From Fragmented Data to Quality Advantage
Clinical data ingestion is often treated as an interoperability obligation. In practice, it is also a performance lever.
HEDIS reporting accuracy depends on how well clinical data is ingested, structured, and made usable. When clinical records are normalized, validated, and made audit-ready at speed, gap closure accelerates. Quality performance improves, revenue potential expands, and operational costs decline.
The National Blue Plan example puts numbers behind that operational reality: 29% more HEDIS gaps closed across 11 key measures, an estimated $128M in additional annual revenue potential, and more than $5M in annual operational savings. For plans focused on quality performance, clinical data ingestion is part of the reporting and performance foundation.
Get in touch to see how HiLabs® CDI can help accelerate HEDIS gap closure for your health plan →